[1]
2023. Impact assessment of expanding the utilization of novel antineoplastic drugs for lung cancer treatment on key performance indicators of the Federal project «Cancer control». Voprosy onkologii. 69, 3 (Jun. 2023), 538–548. DOI:https://doi.org/10.37469/0507-3758-2023-69-3-538-548.